Join the Coagulation Defects and Disorders group to help and get support from people like you.
Coagulation Defects and Disorders News (Page 2)
Risk for Intracerebral Hemorrhage May Be Transmissible Via Blood Transfusion
MONDAY, Sept. 18, 2023 – The risk for spontaneous intracerebral hemorrhage (ICH) is increased for patients who receive red blood cell transfusions from donors who later develop multiple spontaneous...
In Rare Cases, Blood Transfusion Might Cause Brain Hemorrhage
TUESDAY, Sept. 12, 2023 – It’s possible that the cause of spontaneous, recurring brain hemorrhages can be passed through blood transfusion, researchers say. The likelihood of this happening is very s...
Red Cross Appeals for Donors During National Blood Shortage
MONDAY, Sept. 11, 2023 – The American Red Cross said Monday that it urgently needs blood donations because the national blood supply has dropped nearly 25 percent since early August. Back-to-back...
Link Explored for NSAID Use, Hormonal Contraception, VTE Risk
MONDAY, Sept. 11, 2023 – In women of reproductive age, nonsteroidal anti-inflammatory drug (NSAID) use is associated with venous thromboembolism, with significantly more additional events with...
Red Cross Appeals for Donors During National Blood Shortage
MONDAY, Sept. 11, 2023 – The American Red Cross said Monday that it urgently needs blood donations because the national blood supply has dropped nearly 25% since early August. Back-to-back...
Combo of Certain Birth Control Pills, Painkillers Could Raise Women's Clot Risk
FRIDAY, Sept. 8, 2023 – It's well known that certain forms of birth control carry a small risk of blood clots. Now a large new study suggests that some common painkillers can magnify that risk. The...
Pulmonary Embolism-Related Mortality Remained Unchanged From 2006 to 2019
FRIDAY, Sept. 8, 2023 – Mortality related to pulmonary embolism (PE) has remained unchanged since 2006 and is higher among men, Black patients, and those living in rural areas, according to a study...
Concizumab May Be Effective Prophylaxis for Hemophilia A or B With Inhibitors
FRIDAY, Sept. 1, 2023 – Patients with hemophilia A or B with inhibitors have a lower annualized bleeding rate with concizumab than with no prophylaxis, according to a phase 3 study published online...
Why Black People May Be More Prone to Severe Stroke
FRIDAY, July 28, 2023 – Black people tend to be more vulnerable to suffering severe strokes, but scientists have long struggled to figure out why. Until now: New research suggests it may boil down...
FDA Approves Rebinyn (Coagulation Factor IX (Recombinant), GlycoPEGylated) for Patients with Hemophilia B
PLAINSBORO, N.J., May 31, 2017 /PRNewswire/ – Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application for Rebinyn (Coagulation...
FDA Approves Rixubis - First Recombinant Coagulation Factor IX For Use in Preventing Bleeding Episodes
June 27, 2013 – The U.S. Food and Drug Administration yesterday approved Rixubis [Coagulation Factor IX (Recombinant)] for use in people with hemophilia B who are 16 years of age and older. Rixubis...
Ask a question
To post your own question to this support group, sign in or create an account.